Stock Chart IconStock chart icon
BioMarin Pharmaceutical’s year-to-date stock performance.
Stock Chart IconStock chart icon
Union Pacific’s year-to-date stock performance.
Union Pacific: “I think it’s a buy…I think it’s a really good stock to own.”
Stock Chart IconStock chart icon
GitLab’s year-to-date stock performance.
GitLab: “I was prepared for disappointment and I got it…I just do not want enterprise software. I think they’re all too expensive.”
Stock Chart IconStock chart icon
ARS Pharmaceuticals’ year-to-date stock performance.
ARS Pharmaceuticals: “I like their model…It’s a great flier. Someone needs that technology, someone’s going to pay for it.”
Stock Chart IconStock chart icon
NuScale Power’s year-to-date stock performance.
NuScale Power: “…If it does an offering here, that’s when I’d buy. I’d wait for the stock offering after what happened with Oklo tonight.”
